Affluent Medical Sas Stock Current Valuation
| AFME Stock | 1.38 0.04 2.82% |
Valuation analysis of Affluent Medical SAS helps investors to measure Affluent Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Affluent Medical's price fluctuation is very risky at this time. Calculation of the real value of Affluent Medical SAS is based on 3 months time horizon. Increasing Affluent Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Affluent Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Affluent Stock. However, Affluent Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.38 | Real 1.16 | Hype 1.38 | Naive 1.41 |
The real value of Affluent Stock, also known as its intrinsic value, is the underlying worth of Affluent Medical SAS Company, which is reflected in its stock price. It is based on Affluent Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Affluent Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Affluent Medical SAS helps investors to forecast how Affluent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Affluent Medical more accurately as focusing exclusively on Affluent Medical's fundamentals will not take into account other important factors: Affluent Medical SAS Company Current Valuation Analysis
Affluent Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Affluent Medical Current Valuation | 50.42 M |
Most of Affluent Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Affluent Medical SAS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Affluent Medical SAS has a Current Valuation of 50.42 M. This is 99.65% lower than that of the Healthcare sector and 99.59% lower than that of the Medical Devices industry. The current valuation for all France stocks is 99.7% higher than that of the company.
Affluent Medical SAS is rated second in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is presently estimated at about 270.66 Million. Affluent Medical retains roughly 50.42 Million in current valuation claiming about 19% of all equities under Medical Devices industry.Affluent Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.12 | |||
| Operating Margin | (8.42) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 20.6 M | |||
| Shares Owned By Insiders | 3.35 % | |||
| Shares Owned By Institutions | 65.00 % | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 22.19 X | |||
| Gross Profit | (1.29 M) | |||
| EBITDA | (9.87 M) | |||
| Net Income | (14.82 M) | |||
| Cash And Equivalents | 11.41 M | |||
| Total Debt | 17 M | |||
| Book Value Per Share | 1.95 X | |||
| Cash Flow From Operations | (12.36 M) | |||
| Earnings Per Share | (0.77) X | |||
| Target Price | 3.8 | |||
| Number Of Employees | 49 | |||
| Market Capitalization | 30.06 M | |||
| Total Asset | 70.03 M | |||
| Z Score | 0.6 | |||
| Net Asset | 70.03 M |
About Affluent Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Affluent Medical SAS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affluent Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affluent Medical SAS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Affluent Stock
Affluent Medical financial ratios help investors to determine whether Affluent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Affluent with respect to the benefits of owning Affluent Medical security.